Status: current, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4525770013 | Lonafarnib | en | Synonym | Active | Case insensitive | SNOMED CT core |
4525771012 | Lonafarnib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lonafarnib | Is a | Pyridine and/or pyridine derivative | true | Inferred relationship | Some | ||
Lonafarnib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
Lonafarnib | Is a | Transferase inhibitor | true | Inferred relationship | Some | ||
Lonafarnib | Has disposition | Transferase inhibitor | true | Inferred relationship | Some | ||
Lonafarnib | Is a | Antineoplastic agent | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lonafarnib-containing product | Has active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib-containing product in oral dose form | Has active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib 75 mg oral capsule | Has precise active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib 75 mg oral capsule | Has BoSS | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib only product in oral dose form | Has active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib 50 mg oral capsule | Has precise active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib 50 mg oral capsule | Has BoSS | True | Lonafarnib | Inferred relationship | Some | 1 |
Lonafarnib only product | Has active ingredient | True | Lonafarnib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set